Truist Financial Corp purchased a new stake in shares of Sharecare, Inc. (NASDAQ:SHCR – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 27,115 shares of the company’s stock, valued at approximately $29,000.
Other institutional investors have also recently made changes to their positions in the company. Cadent Capital Advisors LLC purchased a new position in shares of Sharecare during the fourth quarter valued at $25,000. Bfsg LLC bought a new stake in Sharecare during the fourth quarter valued at about $41,000. Principal Financial Group Inc. boosted its position in Sharecare by 30.4% during the third quarter. Principal Financial Group Inc. now owns 42,937 shares of the company’s stock valued at $40,000 after purchasing an additional 9,999 shares in the last quarter. Pathstone Family Office LLC bought a new stake in Sharecare during the third quarter valued at about $64,000. Finally, Boston Partners boosted its position in Sharecare by 25.3% during the third quarter. Boston Partners now owns 329,820 shares of the company’s stock valued at $310,000 after purchasing an additional 66,554 shares in the last quarter. Hedge funds and other institutional investors own 35.08% of the company’s stock.
Sharecare Stock Performance
Shares of NASDAQ SHCR opened at $0.86 on Thursday. The company has a market cap of $312.29 million, a PE ratio of -2.33 and a beta of 0.26. The business has a 50-day simple moving average of $0.77 and a two-hundred day simple moving average of $0.93. Sharecare, Inc. has a fifty-two week low of $0.48 and a fifty-two week high of $1.80.
Sharecare (NASDAQ:SHCR – Get Free Report) last released its earnings results on Thursday, May 9th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.04). Sharecare had a negative return on equity of 19.78% and a negative net margin of 30.71%. The firm had revenue of $90.86 million for the quarter, compared to analyst estimates of $103.80 million. During the same period last year, the firm earned ($0.06) EPS. On average, sell-side analysts predict that Sharecare, Inc. will post -0.21 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
SHCR has been the topic of a number of recent research reports. Morgan Stanley dropped their price objective on Sharecare from $1.50 to $1.00 and set an “equal weight” rating on the stock in a research report on Monday, April 15th. BTIG Research downgraded Sharecare from a “buy” rating to a “neutral” rating in a report on Monday, April 1st. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $2.00 price target on shares of Sharecare in a report on Tuesday.
View Our Latest Stock Report on Sharecare
Sharecare Company Profile
Sharecare, Inc operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being.
Read More
Want to see what other hedge funds are holding SHCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sharecare, Inc. (NASDAQ:SHCR – Free Report).
Receive News & Ratings for Sharecare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sharecare and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
